skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: ProQuest Central remove resource type: Standards remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Transcatheter aortic valve implantation for aortic stenosis
Material Type:
Standards
Add to My Research

Transcatheter aortic valve implantation for aortic stenosis

NICE Guidance, 2017

Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

2
Intrapartum care for women with existing medical conditions or obstetric complications and their babies
Material Type:
Standards
Add to My Research

Intrapartum care for women with existing medical conditions or obstetric complications and their babies

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

3
Suspected neurological conditions: recognition and referral
Material Type:
Standards
Add to My Research

Suspected neurological conditions: recognition and referral

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

4
Inotersen for treating hereditary transthyretin amyloidosis
Material Type:
Standards
Add to My Research

Inotersen for treating hereditary transthyretin amyloidosis

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

5
Percutaneous mitral valve leaflet repair for mitral regurgitation
Material Type:
Standards
Add to My Research

Percutaneous mitral valve leaflet repair for mitral regurgitation

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

6
Patisiran for treating hereditary transthyretin amyloidosis
Material Type:
Standards
Add to My Research

Patisiran for treating hereditary transthyretin amyloidosis

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

7
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Material Type:
Standards
Add to My Research

Dapagliflozin for treating chronic heart failure with reduced ejection fraction

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

8
Permanent His-bundle pacemaker implantation for treating heart failure
Material Type:
Standards
Add to My Research

Permanent His-bundle pacemaker implantation for treating heart failure

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

9
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy
Material Type:
Standards
Add to My Research

Tafamidis for treating transthyretin amyloidosis with cardiomyopathy

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

10
Empagliflozin for treating chronic heart failure with reduced ejection fraction
Material Type:
Standards
Add to My Research

Empagliflozin for treating chronic heart failure with reduced ejection fraction

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

11
Avalglucosidase alfa for treating Pompe disease
Material Type:
Standards
Add to My Research

Avalglucosidase alfa for treating Pompe disease

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

12
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
Material Type:
Standards
Add to My Research

Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

13
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy
Material Type:
Standards
Add to My Research

Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2017  (1)
  2. 2017 To 2018  (1)
  3. 2019 To 2020  (5)
  4. 2021 To 2022  (5)
  5. After 2022  (2)
  6. More options open sub menu

Searching Remote Databases, Please Wait